{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:59:02Z","timestamp":1793944742984,"version":"4.8.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["AT010984"],"award-info":[{"award-number":["AT010984"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL180044"],"award-info":[{"award-number":["HL180044"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH075673"],"award-info":[{"award-number":["MH075673"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH135895"],"award-info":[{"award-number":["MH135895"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00759","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:41:11Z","timestamp":1759009271000},"page":"e00759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits"],"prefix":"10.1016","volume":"22","author":[{"given":"Meixiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wathsala","family":"Liyanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Tich\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk\u00e1\u0161","family":"Tenora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyada","family":"Hin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Obayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Majer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangaramanujam M.","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Slusher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatr"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00759_bib2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/da.20540","article-title":"Treatment-resistant depression: recent developments and future directions","volume":"25","author":"Mathew","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.neurot.2025.e00759_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neurot.2025.e00759_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: a multi-scale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"10161","key":"10.1016\/j.neurot.2025.e00759_bib7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00759_bib8","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1192\/bjpo.bp.115.000786","article-title":"High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs","volume":"1","author":"Lieblich","year":"2015","journal-title":"BJPsych Open"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biopsych.2013.03.026","article-title":"Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond","volume":"73","author":"Krystal","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00759_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2025.e00759_bib11","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X15666170703113726","article-title":"Resilience dysregulation in major depressive disorder: focus on glutamatergic imbalance and microglial activation","author":"Reus","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00345492","article-title":"Increased serum glutamate in depressed patients","volume":"232","author":"Kim","year":"1982","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib13","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/s41598-017-05121-6","article-title":"Altered KYN\/TRP, Gln\/Glu, and Met\/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder","volume":"7","author":"Umehara","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00759_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","article-title":"Increased cerebrospinal fluid glutamine levels in depressed patients","volume":"47","author":"Levine","year":"2000","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00759_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.8","article-title":"Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study","volume":"6","author":"Hashimoto","year":"2016","journal-title":"Transl Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00759_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/npjschz.2015.28","article-title":"Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task","volume":"1","author":"Taylor","year":"2015","journal-title":"NPJ Schizophrenia"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/mp.2015.206","article-title":"Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression","volume":"21","author":"Haroon","year":"2016","journal-title":"Mol Psychiatr"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2015.83","article-title":"A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder","volume":"21","author":"Milak","year":"2016","journal-title":"Mol Psychiatr"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00759_bib19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2016.0838","article-title":"Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial","volume":"73","author":"Quiroz","year":"2016","journal-title":"JAMA Psychiatr"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00759_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1570159X14666160321123221","article-title":"Therapeutic modulation of glutamate receptors in major depressive disorder","volume":"15","author":"Jaso","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol Psychiatr"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00759_bib23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatr"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatr"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00759_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatr"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatr"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00759_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"30","key":"10.1016\/j.neurot.2025.e00759_bib31","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11481-013-9442-z","article-title":"Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders","volume":"8","author":"Potter","year":"2013","journal-title":"J Neuroimmune Pharmacol : Off J Soc NeuroImmune Pharmacol"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00759_bib33","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00759_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","article-title":"Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage","volume":"50","author":"Werner","year":"2001","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2013.11.043","article-title":"Small molecule glutaminase inhibitors block glutamate release from stimulated microglia","volume":"443","author":"Thomas","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41386-018-0177-7","article-title":"JHU-083 selectively blocks glutaminase activity in brain CD11b(+) cells and prevents depression-associated behaviors induced by chronic social defeat stress","volume":"44","author":"Zhu","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurot.2025.e00759_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbi.2021.10.009","article-title":"Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression","volume":"99","author":"Ji","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00759_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41593-020-0621-y","article-title":"Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons","volume":"23","author":"Nagy","year":"2020","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00759_bib40","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-17-1148","article-title":"We're not \"DON\" yet: optimal dosing and prodrug delivery of 6-Diazo-5-oxo-L-norleucine","volume":"17","author":"Lemberg","year":"2018","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00759_bib41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/1097-0142(195711\/12)10:6<1138::AID-CNCR2820100608>3.0.CO;2-K","article-title":"Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease","volume":"10","author":"Magill","year":"1957","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00216936","article-title":"Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas","volume":"8","author":"Earhart","year":"1990","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00170760","article-title":"Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON)","volume":"3","author":"Rahman","year":"1985","journal-title":"Invest New Drugs"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00759_bib44","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-21-1204","article-title":"A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors","volume":"27","author":"Harding","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154437","article-title":"Dendrimers target the ischemic lesion in rodent and primate models of nonarteritic anterior ischemic optic neuropathy","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS One"},{"issue":"130","key":"10.1016\/j.neurot.2025.e00759_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci Transl Med"},{"issue":"471","key":"10.1016\/j.neurot.2025.e00759_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0237","article-title":"Cognitive impairments induced by necrotizing enterocolitis can be prevented by inhibiting microglial activation in mouse brain","volume":"10","author":"Nino","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurot.2025.e00759_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2021.05.035","article-title":"Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration","volume":"335","author":"Kambhampati","year":"2021","journal-title":"J Contr Release : Off J Contr Release Soc"},{"issue":"5-6","key":"10.1016\/j.neurot.2025.e00759_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","article-title":"Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications","volume":"15","author":"Menjoge","year":"2010","journal-title":"Drug Discov Today"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00759_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2010.07.030","article-title":"In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation","volume":"399","author":"Inapagolla","year":"2010","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00759_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/jop.2012.0232","article-title":"Dendrimer nanoparticles for ocular drug delivery","volume":"29","author":"Kambhampati","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12974-017-1004-5","article-title":"Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome","volume":"14","author":"Nance","year":"2017","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.neurot.2025.e00759_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2016.05.044","article-title":"Nanoscale effects in dendrimer-mediated targeting of neuroinflammation","volume":"101","author":"Nance","year":"2016","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.25303","article-title":"Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy","volume":"84","author":"Turk","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-016-0529-3","article-title":"Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation","volume":"13","author":"Zhang","year":"2016","journal-title":"J Neuroinflamm"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00759_bib57","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1167\/iovs.14-16250","article-title":"Systemic and intravitreal delivery of dendrimers to activated microglia\/macrophage in ischemia\/reperfusion mouse retina","volume":"56","author":"Kambhampati","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib58","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/nn404872e","article-title":"Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest","volume":"8","author":"Mishra","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.neurot.2025.e00759_bib59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2018.06.003","article-title":"Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model","volume":"283","author":"Sharma","year":"2018","journal-title":"J Contr Release : Off J Contr Release Soc"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00759_bib60","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/acs.bioconjchem.7b00569","article-title":"Activated microglia targeting dendrimer-minocycline conjugate as therapeutics for neuroinflammation","volume":"28","author":"Sharma","year":"2017","journal-title":"Bioconjug Chem"},{"issue":"654","key":"10.1016\/j.neurot.2025.e00759_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2652","article-title":"Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial","volume":"14","author":"Gusdon","year":"2022","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00759_bib62","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.7150\/thno.41714","article-title":"Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome","volume":"10","author":"Khoury","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib63","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/2211-5463.13204","article-title":"Alterations in circulating extracellular vesicles underlie social stress-induced behaviors in mice","volume":"11","author":"Sakamoto","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib64","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41590-023-01447-8","article-title":"Dectin-1 signaling on colonic \u03b3\u03b4 T cells promotes psychosocial stress responses","volume":"24","author":"Zhu","year":"2023","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuron.2018.06.035","article-title":"The innate immune receptors TLR2\/4 mediate repeated social defeat stress-induced social avoidance through prefrontal microglial activation","volume":"99","author":"Nie","year":"2018","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00759_bib66","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat Protoc"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib67","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acs.biomac.0c01270","article-title":"Dendrimer-mediated targeted delivery of rapamycin to tumor-associated macrophages improves systemic treatment of glioblastoma","volume":"21","author":"Sharma","year":"2020","journal-title":"Biomacromolecules"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib68","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/nn.4160","article-title":"Cell type- and brain region-resolved mouse brain proteome","volume":"18","author":"Sharma","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00759_bib69","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-019-09859-w","article-title":"Glutamine antagonist JHU083 normalizes aberrant glutamate production and cognitive deficits in the EcoHIV murine model of HIV-associated neurocognitive disorders","author":"Nedelcovych","year":"2019","journal-title":"J Neuroimmune Pharmacol : Off J Soc NeuroImmune Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib70","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1038\/s41467-023-42276-5","article-title":"Microglial cannabinoid receptor type 1 mediates social memory deficits in mice produced by adolescent THC exposure and 16p11.2 duplication","volume":"14","author":"Hasegawa","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00759_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092364","article-title":"Microglial-targeted nSMase2 inhibitor fails to reduce tau propagation in PS19 mice","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00759_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: computational identification of cell doublets in single-cell transcriptomic data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00759_bib74","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00759_bib76","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1021\/jm301191p","article-title":"Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors","volume":"55","author":"Shukla","year":"2012","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102066","article-title":"Dendrimer-conjugated nSMase2 inhibitor reduces Tau propagation in mice","volume":"14","author":"Tallon","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib78","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biomaterials.2011.10.010","article-title":"Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration","volume":"33","author":"Iezzi","year":"2012","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib79","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1021\/mp400371r","article-title":"Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation","volume":"10","author":"Lesniak","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.neurot.2025.e00759_bib80","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-190588","article-title":"Glutamine antagonist JHU-083 normalizes aberrant hippocampal glutaminase activity and improves cognition in APOE4 mice","author":"Hollinger","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00759_bib81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00759_bib82","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00702-023-02598-6","article-title":"Long-term effects of chronic stress models in adult mice","volume":"130","author":"Tran","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00759_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205232","article-title":"The role of glutamine in the complex interaction between gut microbiota and Health: a narrative review","volume":"20","author":"Perna","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1-M7","key":"10.1016\/j.neurot.2025.e00759_bib84","first-page":"47","article-title":"Role of glutamine in protection of intestinal epithelial tight junctions","volume":"5","author":"Rao","year":"2012","journal-title":"J Epithel Biol Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00759_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051051","article-title":"The roles of glutamine in the intestine and its implication in intestinal diseases","volume":"18","author":"Kim","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00759_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105201","article-title":"Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury","volume":"148","author":"Arteaga Cabeza","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib87","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00213-021-05780-4","article-title":"The role of microglia in chronic pain and depression: innocent bystander or culprit?","volume":"238","author":"Yin","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neurot.2025.e00759_bib88","article-title":"The role of microglia in neuropsychiatric disorders and suicide","author":"Brisch","year":"2021","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00759_bib89","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11427-020-1815-6","article-title":"Microglia in depression: current perspectives","volume":"64","author":"Jia","year":"2021","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.neurot.2025.e00759_bib90","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fncel.2015.00476","article-title":"Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation","volume":"9","author":"Brites","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00759_bib91","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11596-020-2193-1","article-title":"Microglia: a central player in depression","volume":"40","author":"Deng","year":"2020","journal-title":"Curr Med Sci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00759_bib92","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/pcn.13286","article-title":"Inflamed brain: targeting immune changes and inflammation for treatment of depression","volume":"75","author":"Sakamoto","year":"2021","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.neurot.2025.e00759_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109249","article-title":"Minocycline alleviates abnormal microglial phagocytosis of synapses in a mouse model of depression","volume":"220","author":"Han","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2025.e00759_bib94","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnbeh.2017.00207","article-title":"Microglial over-activation by social defeat stress contributes to anxiety- and depressive-like behaviors","volume":"11","author":"Stein","year":"2017","journal-title":"Front Behav Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00759_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051025","article-title":"Preferential and increased uptake of hydroxyl-terminated PAMAM dendrimers by activated microglia in rabbit brain mixed glial culture","volume":"23","author":"Alnasser","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00759_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay8514","article-title":"Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders","volume":"6","author":"Sharma","year":"2020","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00759_bib97","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression","volume":"20","author":"Menard","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00759_bib98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","article-title":"Glutaminase in microglia: a novel regulator of neuroinflammation","volume":"92","author":"Ding","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00759_bib99","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/0271678X221098841","article-title":"Microglial phagocytosis and regulatory mechanisms after stroke","volume":"42","author":"Chen","year":"2022","journal-title":"J Cerebr Blood Flow Metabol : Off J Int Soc Cereb Blood Flow Metabol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00759_bib100","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1007\/s10571-023-01376-y","article-title":"Microglial metabolic reprogramming: emerging insights and therapeutic strategies in neurodegenerative diseases","volume":"43","author":"Miao","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00759_bib101","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s40618-023-02294-y","article-title":"Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer","volume":"47","author":"Zhang","year":"2024","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00759_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10160","article-title":"Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration","volume":"5","author":"Liaw","year":"2020","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.neurot.2025.e00759_bib103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2017.01.032","article-title":"Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model","volume":"249","author":"Zhang","year":"2017","journal-title":"J Contr Release : Off J Contr Release Soc"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:09:43Z","timestamp":1773158983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002375"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00759","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00759"}}